nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLC22A1—Cytarabine—lymphatic system cancer	0.113	0.139	CbGbCtD
Nelfinavir—ABCG2—Teniposide—lymphatic system cancer	0.095	0.116	CbGbCtD
Nelfinavir—ABCG2—Mitoxantrone—lymphatic system cancer	0.0664	0.0813	CbGbCtD
Nelfinavir—CYP1A2—Carmustine—lymphatic system cancer	0.0583	0.0713	CbGbCtD
Nelfinavir—CYP3A5—Teniposide—lymphatic system cancer	0.0526	0.0644	CbGbCtD
Nelfinavir—ABCG2—Vincristine—lymphatic system cancer	0.0457	0.0559	CbGbCtD
Nelfinavir—CYP2C19—Teniposide—lymphatic system cancer	0.0424	0.0519	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—lymphatic system cancer	0.0369	0.0452	CbGbCtD
Nelfinavir—CYP2C9—Teniposide—lymphatic system cancer	0.0353	0.0432	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—lymphatic system cancer	0.0348	0.0426	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0338	0.0413	CbGbCtD
Nelfinavir—CYP3A7—Vincristine—lymphatic system cancer	0.0338	0.0413	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—lymphatic system cancer	0.0277	0.0339	CbGbCtD
Nelfinavir—CYP3A5—Vincristine—lymphatic system cancer	0.0253	0.031	CbGbCtD
Nelfinavir—ABCB1—Mitoxantrone—lymphatic system cancer	0.024	0.0293	CbGbCtD
Nelfinavir—CYP3A4—Cytarabine—lymphatic system cancer	0.0208	0.0255	CbGbCtD
Nelfinavir—CYP3A4—Teniposide—lymphatic system cancer	0.0205	0.0251	CbGbCtD
Nelfinavir—ABCB1—Vincristine—lymphatic system cancer	0.0165	0.0202	CbGbCtD
Nelfinavir—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0144	0.0176	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—lymphatic system cancer	0.00998	0.0122	CbGbCtD
Nelfinavir—CYP3A4—Vincristine—lymphatic system cancer	0.00988	0.0121	CbGbCtD
Nelfinavir—Neutropenia—Vincristine—lymphatic system cancer	0.00057	0.00312	CcSEcCtD
Nelfinavir—Oedema—Fludarabine—lymphatic system cancer	0.000568	0.00311	CcSEcCtD
Nelfinavir—Decreased appetite—Teniposide—lymphatic system cancer	0.000561	0.00308	CcSEcCtD
Nelfinavir—Vomiting—Mechlorethamine—lymphatic system cancer	0.000557	0.00305	CcSEcCtD
Nelfinavir—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000556	0.00304	CcSEcCtD
Nelfinavir—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000555	0.00304	CcSEcCtD
Nelfinavir—Stomatitis—Carmustine—lymphatic system cancer	0.000555	0.00304	CcSEcCtD
Nelfinavir—Rash—Mechlorethamine—lymphatic system cancer	0.000552	0.00303	CcSEcCtD
Nelfinavir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000552	0.00302	CcSEcCtD
Nelfinavir—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000549	0.00301	CcSEcCtD
Nelfinavir—Pneumonia—Vincristine—lymphatic system cancer	0.000547	0.003	CcSEcCtD
Nelfinavir—Anorexia—Fludarabine—lymphatic system cancer	0.000541	0.00296	CcSEcCtD
Nelfinavir—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000536	0.00293	CcSEcCtD
Nelfinavir—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000533	0.00292	CcSEcCtD
Nelfinavir—Feeling abnormal—Teniposide—lymphatic system cancer	0.000532	0.00292	CcSEcCtD
Nelfinavir—Stomatitis—Vincristine—lymphatic system cancer	0.00053	0.0029	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000528	0.00289	CcSEcCtD
Nelfinavir—Sweating—Vincristine—lymphatic system cancer	0.000521	0.00286	CcSEcCtD
Nelfinavir—Nausea—Mechlorethamine—lymphatic system cancer	0.00052	0.00285	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.000519	0.00284	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000517	0.00283	CcSEcCtD
Nelfinavir—Jaundice—Mitoxantrone—lymphatic system cancer	0.000516	0.00283	CcSEcCtD
Nelfinavir—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000516	0.00283	CcSEcCtD
Nelfinavir—Haemoglobin—Carmustine—lymphatic system cancer	0.000514	0.00282	CcSEcCtD
Nelfinavir—Urticaria—Teniposide—lymphatic system cancer	0.000513	0.00281	CcSEcCtD
Nelfinavir—Haemorrhage—Carmustine—lymphatic system cancer	0.000511	0.0028	CcSEcCtD
Nelfinavir—Body temperature increased—Teniposide—lymphatic system cancer	0.000511	0.0028	CcSEcCtD
Nelfinavir—Abdominal pain—Teniposide—lymphatic system cancer	0.000511	0.0028	CcSEcCtD
Nelfinavir—Erythema—Bleomycin—lymphatic system cancer	0.00051	0.00279	CcSEcCtD
Nelfinavir—Paraesthesia—Fludarabine—lymphatic system cancer	0.00051	0.00279	CcSEcCtD
Nelfinavir—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000508	0.00278	CcSEcCtD
Nelfinavir—Sweating—Mitoxantrone—lymphatic system cancer	0.000508	0.00278	CcSEcCtD
Nelfinavir—Dyspnoea—Fludarabine—lymphatic system cancer	0.000506	0.00277	CcSEcCtD
Nelfinavir—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000502	0.00275	CcSEcCtD
Nelfinavir—Dyspepsia—Fludarabine—lymphatic system cancer	0.0005	0.00274	CcSEcCtD
Nelfinavir—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.000499	0.00273	CcSEcCtD
Nelfinavir—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000497	0.00272	CcSEcCtD
Nelfinavir—Decreased appetite—Fludarabine—lymphatic system cancer	0.000493	0.0027	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00049	0.00268	CcSEcCtD
Nelfinavir—Inflammation—Methotrexate—lymphatic system cancer	0.000486	0.00266	CcSEcCtD
Nelfinavir—Pain—Fludarabine—lymphatic system cancer	0.000485	0.00266	CcSEcCtD
Nelfinavir—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00048	0.00263	CcSEcCtD
Nelfinavir—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00048	0.00263	CcSEcCtD
Nelfinavir—Eye disorder—Carmustine—lymphatic system cancer	0.000478	0.00262	CcSEcCtD
Nelfinavir—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000478	0.00262	CcSEcCtD
Nelfinavir—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000477	0.00261	CcSEcCtD
Nelfinavir—Hypersensitivity—Teniposide—lymphatic system cancer	0.000476	0.00261	CcSEcCtD
Nelfinavir—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000475	0.0026	CcSEcCtD
Nelfinavir—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000475	0.0026	CcSEcCtD
Nelfinavir—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000473	0.00259	CcSEcCtD
Nelfinavir—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000472	0.00258	CcSEcCtD
Nelfinavir—Anaemia—Bleomycin—lymphatic system cancer	0.000471	0.00258	CcSEcCtD
Nelfinavir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000468	0.00256	CcSEcCtD
Nelfinavir—Asthenia—Teniposide—lymphatic system cancer	0.000463	0.00254	CcSEcCtD
Nelfinavir—Malaise—Bleomycin—lymphatic system cancer	0.00046	0.00252	CcSEcCtD
Nelfinavir—Pruritus—Teniposide—lymphatic system cancer	0.000457	0.0025	CcSEcCtD
Nelfinavir—Leukopenia—Bleomycin—lymphatic system cancer	0.000456	0.0025	CcSEcCtD
Nelfinavir—Body temperature increased—Fludarabine—lymphatic system cancer	0.000449	0.00246	CcSEcCtD
Nelfinavir—Malnutrition—Carmustine—lymphatic system cancer	0.000445	0.00244	CcSEcCtD
Nelfinavir—Erythema—Carmustine—lymphatic system cancer	0.000445	0.00244	CcSEcCtD
Nelfinavir—Angiopathy—Vincristine—lymphatic system cancer	0.000443	0.00243	CcSEcCtD
Nelfinavir—Diarrhoea—Teniposide—lymphatic system cancer	0.000442	0.00242	CcSEcCtD
Nelfinavir—Myalgia—Bleomycin—lymphatic system cancer	0.000434	0.00238	CcSEcCtD
Nelfinavir—Back pain—Carmustine—lymphatic system cancer	0.000431	0.00236	CcSEcCtD
Nelfinavir—Discomfort—Bleomycin—lymphatic system cancer	0.000429	0.00235	CcSEcCtD
Nelfinavir—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000426	0.00234	CcSEcCtD
Nelfinavir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000418	0.00229	CcSEcCtD
Nelfinavir—Oedema—Bleomycin—lymphatic system cancer	0.000416	0.00228	CcSEcCtD
Nelfinavir—Erythema—Mitoxantrone—lymphatic system cancer	0.000414	0.00227	CcSEcCtD
Nelfinavir—Anaemia—Carmustine—lymphatic system cancer	0.000411	0.00225	CcSEcCtD
Nelfinavir—Back pain—Vincristine—lymphatic system cancer	0.000411	0.00225	CcSEcCtD
Nelfinavir—Vomiting—Teniposide—lymphatic system cancer	0.000411	0.00225	CcSEcCtD
Nelfinavir—Agitation—Carmustine—lymphatic system cancer	0.000409	0.00224	CcSEcCtD
Nelfinavir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000407	0.00223	CcSEcCtD
Nelfinavir—Asthenia—Fludarabine—lymphatic system cancer	0.000407	0.00223	CcSEcCtD
Nelfinavir—Rash—Teniposide—lymphatic system cancer	0.000407	0.00223	CcSEcCtD
Nelfinavir—Dermatitis—Teniposide—lymphatic system cancer	0.000407	0.00223	CcSEcCtD
Nelfinavir—Headache—Teniposide—lymphatic system cancer	0.000405	0.00222	CcSEcCtD
Nelfinavir—Pruritus—Fludarabine—lymphatic system cancer	0.000402	0.0022	CcSEcCtD
Nelfinavir—Back pain—Mitoxantrone—lymphatic system cancer	0.0004	0.00219	CcSEcCtD
Nelfinavir—Leukopenia—Carmustine—lymphatic system cancer	0.000398	0.00218	CcSEcCtD
Nelfinavir—Anorexia—Bleomycin—lymphatic system cancer	0.000397	0.00217	CcSEcCtD
Nelfinavir—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000394	0.00216	CcSEcCtD
Nelfinavir—Anaemia—Vincristine—lymphatic system cancer	0.000393	0.00215	CcSEcCtD
Nelfinavir—Agitation—Vincristine—lymphatic system cancer	0.00039	0.00214	CcSEcCtD
Nelfinavir—Diarrhoea—Fludarabine—lymphatic system cancer	0.000388	0.00213	CcSEcCtD
Nelfinavir—Convulsion—Carmustine—lymphatic system cancer	0.000386	0.00211	CcSEcCtD
Nelfinavir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000384	0.0021	CcSEcCtD
Nelfinavir—Nausea—Teniposide—lymphatic system cancer	0.000384	0.0021	CcSEcCtD
Nelfinavir—Anaemia—Mitoxantrone—lymphatic system cancer	0.000382	0.00209	CcSEcCtD
Nelfinavir—Leukopenia—Vincristine—lymphatic system cancer	0.00038	0.00208	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000379	0.00208	CcSEcCtD
Nelfinavir—Myalgia—Carmustine—lymphatic system cancer	0.000379	0.00208	CcSEcCtD
Nelfinavir—Anxiety—Carmustine—lymphatic system cancer	0.000378	0.00207	CcSEcCtD
Nelfinavir—Paraesthesia—Bleomycin—lymphatic system cancer	0.000374	0.00205	CcSEcCtD
Nelfinavir—Malaise—Mitoxantrone—lymphatic system cancer	0.000373	0.00204	CcSEcCtD
Nelfinavir—Dyspnoea—Bleomycin—lymphatic system cancer	0.000371	0.00203	CcSEcCtD
Nelfinavir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00037	0.00203	CcSEcCtD
Nelfinavir—Convulsion—Vincristine—lymphatic system cancer	0.000368	0.00202	CcSEcCtD
Nelfinavir—Oedema—Carmustine—lymphatic system cancer	0.000363	0.00199	CcSEcCtD
Nelfinavir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000362	0.00198	CcSEcCtD
Nelfinavir—Myalgia—Vincristine—lymphatic system cancer	0.000362	0.00198	CcSEcCtD
Nelfinavir—Vomiting—Fludarabine—lymphatic system cancer	0.000361	0.00198	CcSEcCtD
Nelfinavir—Convulsion—Mitoxantrone—lymphatic system cancer	0.000359	0.00196	CcSEcCtD
Nelfinavir—Rash—Fludarabine—lymphatic system cancer	0.000358	0.00196	CcSEcCtD
Nelfinavir—Dermatitis—Fludarabine—lymphatic system cancer	0.000358	0.00196	CcSEcCtD
Nelfinavir—Pain—Bleomycin—lymphatic system cancer	0.000356	0.00195	CcSEcCtD
Nelfinavir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000356	0.00195	CcSEcCtD
Nelfinavir—Headache—Fludarabine—lymphatic system cancer	0.000356	0.00195	CcSEcCtD
Nelfinavir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000352	0.00193	CcSEcCtD
Nelfinavir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000352	0.00193	CcSEcCtD
Nelfinavir—Anxiety—Mitoxantrone—lymphatic system cancer	0.000351	0.00192	CcSEcCtD
Nelfinavir—Discomfort—Mitoxantrone—lymphatic system cancer	0.000348	0.00191	CcSEcCtD
Nelfinavir—Oedema—Vincristine—lymphatic system cancer	0.000347	0.0019	CcSEcCtD
Nelfinavir—Anorexia—Carmustine—lymphatic system cancer	0.000346	0.0019	CcSEcCtD
Nelfinavir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000343	0.00188	CcSEcCtD
Nelfinavir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00034	0.00186	CcSEcCtD
Nelfinavir—Oedema—Mitoxantrone—lymphatic system cancer	0.000338	0.00185	CcSEcCtD
Nelfinavir—Nausea—Fludarabine—lymphatic system cancer	0.000337	0.00185	CcSEcCtD
Nelfinavir—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000335	0.00184	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000331	0.00181	CcSEcCtD
Nelfinavir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000331	0.00181	CcSEcCtD
Nelfinavir—Urticaria—Bleomycin—lymphatic system cancer	0.000331	0.00181	CcSEcCtD
Nelfinavir—Anorexia—Vincristine—lymphatic system cancer	0.000331	0.00181	CcSEcCtD
Nelfinavir—Body temperature increased—Bleomycin—lymphatic system cancer	0.000329	0.0018	CcSEcCtD
Nelfinavir—Insomnia—Carmustine—lymphatic system cancer	0.000329	0.0018	CcSEcCtD
Nelfinavir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000328	0.0018	CcSEcCtD
Nelfinavir—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000326	0.00179	CcSEcCtD
Nelfinavir—Paraesthesia—Carmustine—lymphatic system cancer	0.000326	0.00179	CcSEcCtD
Nelfinavir—Mood swings—Methotrexate—lymphatic system cancer	0.000324	0.00178	CcSEcCtD
Nelfinavir—Dyspnoea—Carmustine—lymphatic system cancer	0.000324	0.00177	CcSEcCtD
Nelfinavir—Somnolence—Carmustine—lymphatic system cancer	0.000323	0.00177	CcSEcCtD
Nelfinavir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000322	0.00176	CcSEcCtD
Nelfinavir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000316	0.00173	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000316	0.00173	CcSEcCtD
Nelfinavir—Decreased appetite—Carmustine—lymphatic system cancer	0.000316	0.00173	CcSEcCtD
Nelfinavir—Insomnia—Vincristine—lymphatic system cancer	0.000314	0.00172	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000314	0.00172	CcSEcCtD
Nelfinavir—Paraesthesia—Vincristine—lymphatic system cancer	0.000311	0.00171	CcSEcCtD
Nelfinavir—Pain—Carmustine—lymphatic system cancer	0.000311	0.0017	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000308	0.00169	CcSEcCtD
Nelfinavir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000307	0.00168	CcSEcCtD
Nelfinavir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000303	0.00166	CcSEcCtD
Nelfinavir—Decreased appetite—Vincristine—lymphatic system cancer	0.000301	0.00165	CcSEcCtD
Nelfinavir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000301	0.00165	CcSEcCtD
Nelfinavir—Somnolence—Mitoxantrone—lymphatic system cancer	0.0003	0.00164	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000299	0.00164	CcSEcCtD
Nelfinavir—Feeling abnormal—Carmustine—lymphatic system cancer	0.000299	0.00164	CcSEcCtD
Nelfinavir—Asthenia—Bleomycin—lymphatic system cancer	0.000299	0.00164	CcSEcCtD
Nelfinavir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000297	0.00163	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000297	0.00163	CcSEcCtD
Nelfinavir—Pain—Vincristine—lymphatic system cancer	0.000297	0.00162	CcSEcCtD
Nelfinavir—Pruritus—Bleomycin—lymphatic system cancer	0.000294	0.00161	CcSEcCtD
Nelfinavir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000294	0.00161	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—lymphatic system cancer	0.00029	0.00159	CcSEcCtD
Nelfinavir—Pain—Mitoxantrone—lymphatic system cancer	0.000289	0.00158	CcSEcCtD
Nelfinavir—Abdominal pain—Carmustine—lymphatic system cancer	0.000287	0.00157	CcSEcCtD
Nelfinavir—Body temperature increased—Carmustine—lymphatic system cancer	0.000287	0.00157	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000284	0.00155	CcSEcCtD
Nelfinavir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000278	0.00152	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—lymphatic system cancer	0.000277	0.00152	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000276	0.00151	CcSEcCtD
Nelfinavir—Body temperature increased—Vincristine—lymphatic system cancer	0.000274	0.0015	CcSEcCtD
Nelfinavir—Abdominal pain—Vincristine—lymphatic system cancer	0.000274	0.0015	CcSEcCtD
Nelfinavir—Urticaria—Mitoxantrone—lymphatic system cancer	0.000268	0.00147	CcSEcCtD
Nelfinavir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000268	0.00147	CcSEcCtD
Nelfinavir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000267	0.00146	CcSEcCtD
Nelfinavir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000267	0.00146	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—lymphatic system cancer	0.000265	0.00145	CcSEcCtD
Nelfinavir—Vomiting—Bleomycin—lymphatic system cancer	0.000265	0.00145	CcSEcCtD
Nelfinavir—Rash—Bleomycin—lymphatic system cancer	0.000262	0.00144	CcSEcCtD
Nelfinavir—Dermatitis—Bleomycin—lymphatic system cancer	0.000262	0.00144	CcSEcCtD
Nelfinavir—Asthenia—Carmustine—lymphatic system cancer	0.000261	0.00143	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—lymphatic system cancer	0.000257	0.00141	CcSEcCtD
Nelfinavir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000255	0.0014	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—lymphatic system cancer	0.000253	0.00139	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00025	0.00137	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—lymphatic system cancer	0.000249	0.00136	CcSEcCtD
Nelfinavir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000249	0.00136	CcSEcCtD
Nelfinavir—Asthenia—Vincristine—lymphatic system cancer	0.000249	0.00136	CcSEcCtD
Nelfinavir—Diarrhoea—Carmustine—lymphatic system cancer	0.000249	0.00136	CcSEcCtD
Nelfinavir—Nausea—Bleomycin—lymphatic system cancer	0.000247	0.00135	CcSEcCtD
Nelfinavir—Asthenia—Mitoxantrone—lymphatic system cancer	0.000242	0.00133	CcSEcCtD
Nelfinavir—Dizziness—Carmustine—lymphatic system cancer	0.00024	0.00132	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—lymphatic system cancer	0.000238	0.0013	CcSEcCtD
Nelfinavir—Diarrhoea—Vincristine—lymphatic system cancer	0.000237	0.0013	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—lymphatic system cancer	0.000237	0.0013	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—lymphatic system cancer	0.000237	0.0013	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—lymphatic system cancer	0.000235	0.00129	CcSEcCtD
Nelfinavir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000231	0.00127	CcSEcCtD
Nelfinavir—Vomiting—Carmustine—lymphatic system cancer	0.000231	0.00127	CcSEcCtD
Nelfinavir—Dizziness—Vincristine—lymphatic system cancer	0.000229	0.00126	CcSEcCtD
Nelfinavir—Rash—Carmustine—lymphatic system cancer	0.000229	0.00125	CcSEcCtD
Nelfinavir—Dermatitis—Carmustine—lymphatic system cancer	0.000229	0.00125	CcSEcCtD
Nelfinavir—Headache—Carmustine—lymphatic system cancer	0.000228	0.00125	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000224	0.00123	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—lymphatic system cancer	0.000221	0.00121	CcSEcCtD
Nelfinavir—Vomiting—Vincristine—lymphatic system cancer	0.00022	0.00121	CcSEcCtD
Nelfinavir—Rash—Vincristine—lymphatic system cancer	0.000219	0.0012	CcSEcCtD
Nelfinavir—Dermatitis—Vincristine—lymphatic system cancer	0.000218	0.0012	CcSEcCtD
Nelfinavir—Headache—Vincristine—lymphatic system cancer	0.000217	0.00119	CcSEcCtD
Nelfinavir—Nausea—Carmustine—lymphatic system cancer	0.000216	0.00118	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—lymphatic system cancer	0.000215	0.00118	CcSEcCtD
Nelfinavir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000215	0.00118	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—lymphatic system cancer	0.000214	0.00117	CcSEcCtD
Nelfinavir—Rash—Mitoxantrone—lymphatic system cancer	0.000213	0.00117	CcSEcCtD
Nelfinavir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000213	0.00117	CcSEcCtD
Nelfinavir—Headache—Mitoxantrone—lymphatic system cancer	0.000212	0.00116	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Nelfinavir—Nausea—Vincristine—lymphatic system cancer	0.000206	0.00113	CcSEcCtD
Nelfinavir—Nausea—Mitoxantrone—lymphatic system cancer	0.000201	0.0011	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—lymphatic system cancer	0.000199	0.00109	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000191	0.00105	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—lymphatic system cancer	0.000191	0.00104	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—lymphatic system cancer	0.000186	0.00102	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—lymphatic system cancer	0.000185	0.00101	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—lymphatic system cancer	0.000179	0.000978	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—lymphatic system cancer	0.000176	0.000961	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—lymphatic system cancer	0.000176	0.000961	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000174	0.000955	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—lymphatic system cancer	0.000173	0.00095	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000165	0.000902	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—lymphatic system cancer	0.000163	0.000895	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000163	0.000891	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—lymphatic system cancer	0.00016	0.000879	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000153	0.00084	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—lymphatic system cancer	0.000152	0.000834	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000151	0.000828	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—lymphatic system cancer	0.00015	0.000822	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—lymphatic system cancer	0.00015	0.000819	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—lymphatic system cancer	0.000148	0.000811	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000146	0.000801	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000145	0.000796	CcSEcCtD
Nelfinavir—Pain—Methotrexate—lymphatic system cancer	0.000144	0.000788	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000139	0.00076	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000138	0.000754	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—lymphatic system cancer	0.000134	0.000732	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000133	0.000729	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—lymphatic system cancer	0.000133	0.000729	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000124	0.000679	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—lymphatic system cancer	0.000121	0.000661	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—lymphatic system cancer	0.000119	0.000652	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000115	0.000631	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—lymphatic system cancer	0.000111	0.000609	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—lymphatic system cancer	0.000107	0.000586	CcSEcCtD
Nelfinavir—Rash—Methotrexate—lymphatic system cancer	0.000106	0.000581	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—lymphatic system cancer	0.000106	0.000581	CcSEcCtD
Nelfinavir—Headache—Methotrexate—lymphatic system cancer	0.000105	0.000577	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—lymphatic system cancer	9.99e-05	0.000547	CcSEcCtD
